Skip to main content
Clinical Trials/NCT05671237
NCT05671237
Completed
Not Applicable

The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block on Perioperative Remifentanil Consumption and Postoperative Pain Scores for Rhinoplasty Operations

Istanbul University1 site in 1 country60 target enrollmentNovember 11, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anesthesia, Local
Sponsor
Istanbul University
Enrollment
60
Locations
1
Primary Endpoint
Remifentanil consumption
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of our study is to examine the effect of bilateral infraorbital and infratrochlear nerve blocks for rhinoplasty operations on perioperative remifentanil need and postoperative pain scores.

Detailed Description

Rhinoplasty operations are one of the most applied cosmetic surgeries in the world. Depending on the procedure type and hemodynamic lability, the quality of the surgical field, perioperative and postoperative complications as well as the success of surgery are affected.To provide improved surgical field quality, controlled hypotension and high concentrations of inhalation anesthetics, magnesium sulfate, remifentanil, clonidine, calcium channel blockers, tranexamic acid, intravenous nitroglycerin have been used. The American Society of Anesthesiology recommends using regional anesthesia methods and administering multimodal analgesia in every possible surgery. In our study we have performed bilaterral infraorbital an infratrochlear nerve blocks which are main nerves of the nose, for the patients of rhinoplasty. With blocking the infratrochlear and infraorbital nerves we will examine the need for remifentanil during surgery, postoperative pain scores.

Registry
clinicaltrials.gov
Start Date
November 11, 2022
End Date
March 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Reyhan Nil Kırsan

Principal Investigator

Istanbul University

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing rhinoplasty surgery

Exclusion Criteria

  • Bleeding disorder
  • Patient refusal
  • Age under 18

Outcomes

Primary Outcomes

Remifentanil consumption

Time Frame: 6 hours

We will compare the remifentanil consumption for the block performed and non-block group

Secondary Outcomes

  • Surgical bleeding grading(6 hours)
  • Numeric rating Scale(6 hours)
  • Post-operative nausea and vomiting(6 hours)
  • Richmond agitation sedation scale(6 hours)
  • Need for analgesic after surgery(6 hours)

Study Sites (1)

Loading locations...

Similar Trials